retatrutide update FDA Approval Status 2026: Everything We Know So Far Retatrutide Where to Get: Can

BMI Requirements and Weight Loss Candidacy Body Mass Index (BMI) serves as the primary screening tool for GLP-1 eligibility

Rule out nutrition, stress, medication interactions

In one trial, 638 patients randomized to 1 of 3 treatment arms following a 1-week lead-in period received: dapagliflozin 10 mg plus metformin HCl extended-release (up to 2,000 mg/day), dapagliflozin 10 mg plus placebo, or metformin HCl extended-release (up to 2,000 mg/day) plus placebo

Transparent, always

The hair shaft remains attached during telogen

Mistake 1: using the wrong concentration chart This is the most common and most dangerous error